Ann R. Kennedy
Researcher Next ID · RN-029863
Researcher · Medicine
Pieris Pharmaceuticals (United States)
Boston, Egypt
- Works count
- 319
- Citation count
- 12,510
- H-index
- 59
- i10-index
- 192
Research interests
Publications
Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System
International Journal of Radiation Oncology*Biology*Physics · 2020 · https://doi.org/10.1016/j.ijrobp.2019.10.049
Limitations in predicting the space radiation health risk for exploration astronauts
Civil War Book Review · 2018
Biological effects of space radiation and development of effective countermeasures
Life Sciences in Space Research · 2014 · https://doi.org/10.1016/j.lssr.2014.02.004
Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development
Journal of Radiological Protection · 2014 · https://doi.org/10.1088/0952-4746/34/2/r25
Second Malignant Neoplasms and Cardiovascular Disease Following Radiotherapy
JNCI Journal of the National Cancer Institute · 2012 · https://doi.org/10.1093/jnci/djr533
The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent
American Journal of Clinical Nutrition · 1998 · https://doi.org/10.1093/ajcn/68.6.1406s
Chemopreventive Agents
Pharmacology & Therapeutics · 1998 · https://doi.org/10.1016/s0163-7258(98)00010-2
The Evidence for Soybean Products as Cancer Preventive Agents
Journal of Nutrition · 1995 · https://doi.org/10.1093/jn/125.3_suppl.733s
Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro.
Proceedings of the National Academy of Sciences · 1985 · https://doi.org/10.1073/pnas.82.16.5395
Relationship between x-ray exposure and malignant transformation in C3H 10T1/2 cells.
Proceedings of the National Academy of Sciences · 1980 · https://doi.org/10.1073/pnas.77.12.7262
Current projects
No projects listed.